VaccinexVCNX
13F holders, Q3 2024 (September 30)12holders +1
2new positions
1sold out
1famous investor
$3.40avg. 13F price*
At the end of Q3 2024, 12 institutions reported holding Vaccinex Inc. (VCNX) in their 13F filings, up 1 from Q2 2024. 2 opened new positions and 1 sold out. The largest holders were Point72 Asset Management ($564K), Armistice Capital, LLC ($558K) and UBS Group AG ($12K). One famous investor held it Steve Cohen (0.0% of Point72 Asset Management's portfolio).
- Company
- Vaccinex Inc.
- CUSIP
- 918640301
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $12K |
| Exits | 1 | $424K |
All 13F filers, Q2 2024 → Q3 2024: 123,458 shares bought and 110,069 shares sold, net +13,389 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 12 holders
| Point72 Asset Management | 0.00% | Add +42.4% | 166,000 | $564K |
| Armistice Capital, LLC | 0.01% | Add +74.5% | 164,000 | $558K |
| UBS Group AG | 0.00% | New | 3,402 | $12K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +42.2% | 1,883 | $6K |
| Group One Trading LLC | 0.00% | No change | 67 | $231 |
| Osaic Holdings, Inc. | 0.00% | No change | 53 | $180 |
| Barclays PLC | 0.00% | New | 27 | $92 |
| Bank of America Corp. | 0.00% | Add +200.0% | 24 | $82 |
| Morgan Stanley | 0.00% | Reduce -99.6% | 4 | $14 |
| Wells Fargo & Company | 0.00% | No change | 2 | $7 |
| Royal Bank of Canada | 0.00% | Reduce -5.1% | 37 | $0 |
| Capital Advisors, Ltd. LLC | 0.00% | No change | 3 | $0 |
"% of holder's portfolio" is VCNX's weight in each manager's 13F, not the share of Vaccinex Inc. the manager owns.